President & CEO of Biotelemetry Inc (BEAT, Financial) Joseph H Capper sold 200,000 shares of BEAT on 06/13/2018 at an average price of $43.86 a share. The total sale was $8.8 million.
BioTelemetry Inc provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Its segments are healthcare, technology and research. BioTelemetry Inc has a market cap of $1.46 billion; its shares were traded at around $44.45 with and P/S ratio of 4.51.
CEO Recent Trades:
- President & CEO Joseph H Capper sold 200,000 shares of BEAT stock on 06/13/2018 at the average price of $43.86. The price of the stock has increased by 1.35% since.
Directors and Officers Recent Trades:
- Director Rebecca W Rimel sold 9,338 shares of BEAT stock on 05/31/2018 at the average price of $42.28. The price of the stock has increased by 5.13% since.
- Director Robert J. Rubin sold 5,000 shares of BEAT stock on 05/24/2018 at the average price of $42. The price of the stock has increased by 5.83% since.
For the complete insider trading history of BEAT, click here
.
